Fig. 1.
Risk of discontinuation of acetylcholinesterase inhibitor (AChEI) use according to AChEI drugs among those diagnosed with Alzheimer’s disease in 2005 in the MEDALZ-2005 study (unadjusted).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.